| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/08/2014 | CN103494751A Honeysuckle mouthwash preparation method |
| 01/08/2014 | CN103494750A Folium isatidis mouthwash |
| 01/08/2014 | CN103494745A Anti-bacterial tea polyphenol wet tissue and preparation method thereof |
| 01/08/2014 | CN103494744A Anti-bacterial pogostemon cablin essential oil wet tissue and preparation method thereof |
| 01/08/2014 | CN103494743A Anti-bacterial geranium essential oil wet tissue and preparation method thereof |
| 01/08/2014 | CN103494742A Evening primrose oil antibacterial wipes and preparation method thereof |
| 01/08/2014 | CN103494727A Jasmine hand cleanser |
| 01/08/2014 | CN103494716A Anti-bacterial aloe wet tissue and preparation method thereof |
| 01/08/2014 | CN103493853A Disinfectant |
| 01/08/2014 | CN103493851A Traditional Chinese medicine disinfectant prepared employing film technology |
| 01/08/2014 | CN103493849A Rose essential oil disinfection gel |
| 01/08/2014 | CN103493847A Environment-friendly immersing and spraying liquid and preparation method thereof |
| 01/08/2014 | CN103110910B Agent for treating acute upper respiratory infection |
| 01/08/2014 | CN103071117B Method for extracting curcuma oil and curcumine from rhizoma curcumae longae |
| 01/08/2014 | CN103055310B Bigeminal inactivated vaccine for avian influenza (H9 sub type) and Escherichia coli and preparation method thereof |
| 01/08/2014 | CN102987092B Feed additive for improving disease resistance of escherichia coli |
| 01/08/2014 | CN102949658B Drug formula for treating hepatitis |
| 01/08/2014 | CN102876620B Nontoxic ST28 streptococcus suis and application thereof |
| 01/08/2014 | CN102861161B Method for preparing traditional Chinese medicine wet tissue for treating scale keratosis type tinea manus and tinea pedis |
| 01/08/2014 | CN102846549B Preparation method for oxytetracycline liposome |
| 01/08/2014 | CN102836428B Inactivated vaccine preparation method for egg yolk antibody for resisting litopenaeus vannamei red body disease |
| 01/08/2014 | CN102807972B Hepatitis A virus purification method |
| 01/08/2014 | CN102793869B Traditional Chinese medicine composition for controlling porcine viral diseases and preparation method thereof |
| 01/08/2014 | CN102755642B Preparing method of anthrax vaccines |
| 01/08/2014 | CN102755620B Appetizing health care product used for hepatitis B patients |
| 01/08/2014 | CN102641225B Cosmetic containing plant bacteriostatic composition |
| 01/08/2014 | CN102631571B Method for preparing traditional Chinese medicine lotion for treating drinking-type furuncle on sole |
| 01/08/2014 | CN102492661B Preparation method and application of immunization preparation for controlling novel duck reovirus |
| 01/08/2014 | CN102406922B Compound long-acting norfloxacin nicotinate suspension for livestock and preparation method thereof |
| 01/08/2014 | CN102349543B Application of calcined shell/nanometer Cu2O composite |
| 01/08/2014 | CN102234280B D, L-guanosine analogs, preparation methods thereof and applications thereof |
| 01/08/2014 | CN101565458B Peptide vaccine for animal and preparation method thereof |
| 01/08/2014 | CN101547698B Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses |
| 01/07/2014 | US8624025 Antiviral agents |
| 01/07/2014 | US8623881 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 01/07/2014 | US8623833 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 01/07/2014 | US8623815 TRIM5alpha mutants and uses thereof |
| 01/07/2014 | US8623814 Antiviral agents |
| 01/07/2014 | US8623609 Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents |
| 01/07/2014 | US8623388 Denture care composition |
| 01/07/2014 | US8623379 Compositions and methods for generating an immune response |
| 01/07/2014 | US8623353 TLR2 antagonistic antibody and use thereof |
| 01/07/2014 | CA2774961C Oral care compositions comprising increased bioavailable levels of quaternary ammonium antimicrobials |
| 01/07/2014 | CA2716838C Ccr5 antagonists as prophylactics for preventing hiv infection and methods of inhibiting transmission of same |
| 01/07/2014 | CA2680018C Combination medicaments for treating bacterial infections |
| 01/07/2014 | CA2664915C Pharmaceutical composition comprising phenylamidine derivative and method of using the pharmaceutical composition in combination with antifungal agent |
| 01/07/2014 | CA2656604C Injectable formulation of antibiotic and solution for intravenous administration thereof |
| 01/07/2014 | CA2609875C Crystalline solid forms of tigecycline and methods of preparing same |
| 01/07/2014 | CA2602800C Pyrazolopyridines and analogs thereof |
| 01/07/2014 | CA2560922C Improvements in or relating to compounds for use in the treatment of aids and other viral diseases and hiv-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions |
| 01/07/2014 | CA2464472C Antibody targeting compounds |
| 01/07/2014 | CA2453967C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/07/2014 | CA2336875C Multivalent human-bovine rotavirus vaccine |
| 01/07/2014 | CA2319404C Recombinant lipidated psaa protein, methods of preparation and use |
| 01/03/2014 | WO2014004674A2 Methods for treating hcv |
| 01/03/2014 | WO2014004416A1 Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drug |
| 01/03/2014 | WO2014003850A2 Methods for treatment of ocular diseases |
| 01/03/2014 | WO2014003694A1 Synthesis of thiosemicarbazides and triazoles derived from etodolac |
| 01/03/2014 | WO2014003693A1 Etodolac derivatives as hcv ns5b polymerase inhibitors |
| 01/03/2014 | WO2014003536A1 Dosage regime of fusion compounds |
| 01/03/2014 | WO2014003069A1 Crustacean feed |
| 01/03/2014 | WO2014001924A1 Antibacterial microelement chelates and the use thereof in animal feeds |
| 01/03/2014 | WO2014001882A1 Composition comprising a sesterterpene and use thereof as antibiotic and antifungal adjuvant |
| 01/03/2014 | WO2014001782A1 Antimicrobial compounds |
| 01/03/2014 | WO2014001775A1 Antimicrobial compounds |
| 01/03/2014 | WO2014001749A1 Formulation comprising crh and alpha - 2 - immunoglobulin |
| 01/03/2014 | WO2014001444A1 Dosing instructions for endotoxin-binding lipopeptides |
| 01/03/2014 | WO2014001353A1 Pharmaceutical compositions and treatment of mastitis |
| 01/03/2014 | WO2014000541A1 Acyclic nucleotide analogue, preparation method therefor, and application thereof |
| 01/03/2014 | WO2014000178A1 Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drug |
| 01/03/2014 | WO2014000032A1 Phenyl amino pyrimidine bicyclic compounds and uses thereof |
| 01/03/2014 | WO2013156861A3 Methods and compounds for treating proliferative disorders and viral infections |
| 01/03/2014 | WO2013142628A4 Antibiotic compounds and compositions, and methods for identification thereof |
| 01/03/2014 | WO2009158026A9 Hydrazonamide compounds that modulate hsp90 activity |
| 01/03/2014 | CA2877998A1 Antibacterial microelement chelates and the use thereof in animal feeds |
| 01/03/2014 | CA2877941A1 Compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 01/03/2014 | CA2877923A1 Phenyl amino pyrimidine bicyclic compounds and uses thereof |
| 01/03/2014 | CA2877794A1 Pharmaceutical compositions and treatment of mastitis |
| 01/03/2014 | CA2877598A1 A human monoclonal antibody against the vp1 protein of jc virus |
| 01/03/2014 | CA2877562A1 Formulation comprising crh and alpha-2-immunoglobulin |
| 01/03/2014 | CA2877326A1 Cyanoguanidines and their use as antiviral agents |
| 01/03/2014 | CA2877272A1 Dosage regime of fusion compounds |
| 01/03/2014 | CA2877130A1 Temperature stable vaccine formulations |
| 01/03/2014 | CA2876496A1 Methods for treating hcv |
| 01/03/2014 | CA2876240A1 Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drug |
| 01/03/2014 | CA2876158A1 Antimicrobial compounds |
| 01/03/2014 | CA2876157A1 Antimicrobial compounds |
| 01/02/2014 | US20140005371 Caprazene as a novel compound and derivatives thereof, and caprazol as a novel compound and derivatives thereof |
| 01/02/2014 | US20140004143 Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor |
| 01/02/2014 | US20140004136 Phosphorylated derivatives of a u1-70k peptide and their use in the treatment of autoimmune pathologies |
| 01/02/2014 | US20140004123 Monoclonal antibody production by ebv transformation of b cells |
| 01/02/2014 | US20140004113 Defensin-antigen fusion proteins |
| 01/02/2014 | US20140004095 Albumin fusion proteins |
| 01/02/2014 | US20140004077 Method for treating cervical cancer |
| 01/01/2014 | EP2679681A1 Fc riib-specific fc antibody |
| 01/01/2014 | EP2679574A1 Hydrated n-fullerene amino acids, method for producing the latter, and pharmaceutical compositions on the basis thereof |
| 01/01/2014 | EP2679247A1 Carboxylic mannan-coated contrast agent for magnetic resonance imaging |
| 01/01/2014 | EP2679240A1 Vaccines including antigen from four strains of influenza virus |
| 01/01/2014 | EP2679236A1 Metering guide for lipopeptides that bind endotoxin |
| 01/01/2014 | EP2678349A1 C-4" position substituted macrolide derivative |